Risk stratification in childhood hypertrophic cardiomyopathy
نویسندگان
چکیده
منابع مشابه
Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment.
mon inherited cardiomyopathy, occurring in about 1 in 500 individuals. The first gene mutation for this condition was identified in a large French Canadian family cohort in 1989. Clinical presentation typically includes left ventricular hypertrophy in the absence of abnormal loading conditions, such as hypertension or aortic stenosis. Hypertrophic cardiomyopathy has come to public recognition i...
متن کاملRisk stratification in hypertrophic cardiomyopathy: fact or fiction?
Hypertrophic cardiomyopathy (HCM) is an inherited cardiac muscle disease that affects sarcomeric proteins, resulting in severe hypertrophy, myofibrillar disorganization, and enhanced interstitial fibrosis. The disease is often familial, with autosomal-dominant transmission. More than 100 different mutations in 10 genes that encode sarcomeric proteins have been described (1–3). Hypertrophy typic...
متن کاملRisk stratification and prevention of sudden death in hypertrophic cardiomyopathy.
Sudden unexpected death, often occurring in young, asymptomatic patients, is the most devastating facet of the natural history of hypertrophic cardiomyopathy, and appears to be the consequence of primary ventricular tachyarrhythmias arising in an electrically unstable myocardial substrate characterized by disorganized cellular architecture, ischemia, cell death, and replacement scarring. Althou...
متن کاملHypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death.
http://heart.bmj.com/cgi/content/full/87/2/169 Updated information and services can be found at: These include: Data supplement http://heart.bmj.com/cgi/content/full/87/2/169/DC1 "Web only references" References http://heart.bmj.com/cgi/content/full/87/2/169#otherarticles 16 online articles that cite this article can be accessed at: http://heart.bmj.com/cgi/content/full/87/2/169#BIBL This artic...
متن کاملContemporary considerations for risk stratification, sudden death and prevention in hypertrophic cardiomyopathy.
Sudden death has been the most devastating, unpredictable and recognisable complication of hypertrophic cardiomyopathy (HCM), since the modern description of the disease by Teare over 40 years ago. HCM is now recognised as the most common cause of sudden cardiac death in young people, including trained athletes, 3 although only a minority of all HCM patients are susceptible to the risk of sudde...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Global Cardiology Science and Practice
سال: 2018
ISSN: 2305-7823
DOI: 10.21542/gcsp.2018.24